Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

GUAIFENESIN AND DEXTROMETHORPHAN HYDROBR

Awarded
SPE2D926F8695Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Defense Logistics Agency award SPE2D926F8695 is a delivery order issued on September 3, 2026, to Cardinal Health, Inc. for the procurement of Guaifenesin and Dextromethorphan Hydrobromide. This specific order, valued at 334.50, covers the supply of 50 units of the medication for delivery to the USS Paul Hamilton (DDG 60). This delivery order was placed under the broader fleet milstrip contract SPE2DX25D8022, which was originally awarded to Cardinal Health, Inc. on March 7, 2025, by DLA Troop Support Medical Supply Chain for a total value of 20,000,000.00. The procurement is managed by the Department of Defense to ensure the necessary medical supplies are provided to naval operations.

General Info

Contract Value

$334.5

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

(2)

SPE2D9-26-F-8695 - Order for Supplies or Services

PDF•task-order-award

SPE2DX-25-D-8022 - Award to Cardinal Health, Inc.

PDF•award

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2D926F8695 posted on DIBBS. Awardee: CARDINAL HEALTH, INC. (CAGE 00E55) Total Contract Price: $334.50 Award Date: 09-03-2026 Delivery order under: SPE2DX25D8022 Line items: - GUAIFENESIN AND DEXTROMETHORPHAN HYDROBR (NSN/Part 6505015603527, PR 7018191728)

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
DIBBS
IOHEXOL INJECTION, U
Solicitation # SPE2DP-26-T-5185
This fixed-price solicitation, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, seeks quotes for the procurement of IOHEXOL INJECTION, USP. The product is a radiological contrast media consisting of 300mg/ml injections provided in 150ml polymer bottles, with a unit of issue defined as a box. The requirement is split into two line items, each for a quantity of two boxes, with a total of four boxes requested. Delivery is required within five days of order, with specific destination delivery dates set for June 18 and June 22, 2026. Shipments are directed to the Naval Med Readiness Logistics Command in Williamsburg, Virginia, and the USS Iwo Jima LHD 7. The contract mandates strict adherence to quality and safety standards, including USP pharmacopeia standards and a non-extendable 36-month shelf-life requirement. Packaging must be commercial and compliant with DLA packaging requirements, specifically RP001 and Medical Marking Standard No. 1. For hazardous materials, suppliers must provide Safety Data Sheets and labels conforming to the Hazard Communication Standard and the UN Globally Harmonized System. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, domestic sourcing, and the safeguarding of covered defense information.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

in 2 days
View Details
NAICS: 424210
New
DIBBS
BENZOIN TINCTURE, COMPO
Solicitation # SPE2DP-26-T-5290
This solicitation, issued by DLA Troop Support Medical Supply Chain Pharm FSA under number SPE2DP-26-T-5290, is a request for quotations for Compound Benzoin Tincture, USP. The product is an over-the-counter topical solution for external use, containing 1000 mg of benzoin resin per 1 ml and 77 percent alcohol as an inactive ingredient. The requirement consists of two line items totaling five 16-ounce bottles. This is a fixed-price acquisition with a 20-day delivery requirement, and the items are to be delivered FOB Destination to specified locations, including sites in Germany and California. The contract includes stringent technical, safety, and quality requirements. The item is classified as a Type I (Code Q) item with a 36-month shelf life, requiring a minimum of 31 months of remaining shelf life at the time of receipt. Because the tincture is flammable and contains alcohol, it is classified as hazardous material; therefore, the contractor must provide a current Material Safety Data Sheet (MSDS) with each shipment and ensure packaging complies with 49 CFR and ICAO or IMDG regulations. Marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Additionally, the procurement is subject to domestic preference regulations, including the Buy American Act and the Berry Amendment, and requires compliance with cybersecurity standards for safeguarding covered defense information. Quotations must be submitted via the DIBBS system by the October 5, 2026, deadline.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
ALBENDAZOLE TABLETS
Solicitation # SPE2DP-26-T-5312
This solicitation, issued by the DLA Troop Support Medical Supply Chain on September 29, 2026, is a Request for Quotations for Albendazole Tablets, USP. The procurement consists of two separate line items: one for 2 bottles and another for 56 bottles, with each bottle containing two 200 mg tablets. The items are FDA-regulated and must meet a Type I (Code M) shelf-life requirement of 24 months, which is non-extendable. Storage requirements mandate a controlled room temperature between 20° to 25°C (68° to 77°F). This is not a small business set-aside, and quotes must be submitted via the DIBBS system by the deadline of October 5, 2026. The contract specifies destination-based inspection and acceptance, with delivery required within five days. Shipping destinations include the USS Gettysburg CG 64 at FPO AA 34091 and USALRCTR Bavaria in Germany. Packaging must be commercial and suitable for protecting contents from damage, with specific protocols for hazardous versus non-hazardous materials. Marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various federal and defense regulations, including requirements for safeguarding covered defense information, cybersecurity reporting, and compliance with the Buy American Act. Additionally, the government prohibits the use of additive manufacturing for any supplied parts or supplies unless specifically authorized.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 23 hours ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS